论文信息 - Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature - 字舞流文

Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature

K. Cowan | W. Audeh | P. Whitworth | P. Beitsch | P. Kelemen | J. Pellicane | P. Baron | W. Dooley | R. Rahman | A. Ashikari | M. Gittleman | B. Lesnikoski | Carrie L. Dul | Laura A. Lee | Maryann Murray | R. Budway | D. Rock | J. Barone | B. Dupree | Shiyu Wang | A. Menicucci | E. Yoder | C. Finn | Kate Corcoran | L. Blumencranz | C. Dul | M. Murray